SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 278 filers reported holding SAGE THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 1.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $631,714 | +55.0% | 13,435 | +38.3% | 0.00% | – |
Q1 2023 | $407,683 | +69.5% | 9,716 | +54.1% | 0.00% | – |
Q4 2022 | $240,473 | -66.9% | 6,305 | -35.0% | 0.00% | -100.0% |
Q1 2021 | $726,000 | -34.2% | 9,702 | -24.0% | 0.00% | 0.0% |
Q4 2020 | $1,104,000 | -81.3% | 12,760 | -86.8% | 0.00% | -85.7% |
Q3 2020 | $5,897,000 | +418.6% | 96,485 | +252.9% | 0.01% | +250.0% |
Q2 2020 | $1,137,000 | +89.2% | 27,338 | +30.5% | 0.00% | +100.0% |
Q1 2020 | $601,000 | -3.4% | 20,941 | +143.2% | 0.00% | 0.0% |
Q4 2019 | $622,000 | -87.4% | 8,610 | -75.6% | 0.00% | -85.7% |
Q3 2019 | $4,946,000 | -27.8% | 35,258 | -5.7% | 0.01% | -30.0% |
Q2 2019 | $6,846,000 | +30.0% | 37,391 | +12.9% | 0.01% | +25.0% |
Q1 2019 | $5,266,000 | +144.2% | 33,107 | +47.1% | 0.01% | +100.0% |
Q4 2018 | $2,156,000 | -30.2% | 22,505 | +2.9% | 0.00% | -20.0% |
Q3 2018 | $3,090,000 | +6.5% | 21,874 | +18.0% | 0.01% | 0.0% |
Q2 2018 | $2,901,000 | +26.6% | 18,533 | +30.2% | 0.01% | +25.0% |
Q1 2018 | $2,292,000 | -4.6% | 14,229 | -2.4% | 0.00% | 0.0% |
Q4 2017 | $2,402,000 | +172.0% | 14,581 | +2.9% | 0.00% | +100.0% |
Q3 2017 | $883,000 | -51.4% | 14,167 | -37.9% | 0.00% | -50.0% |
Q2 2017 | $1,816,000 | +79.4% | 22,798 | +60.1% | 0.00% | +100.0% |
Q1 2017 | $1,012,000 | -19.0% | 14,237 | -41.8% | 0.00% | -33.3% |
Q4 2016 | $1,249,000 | +266.3% | 24,455 | +230.3% | 0.00% | +200.0% |
Q3 2016 | $341,000 | – | 7,404 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DAFNA Capital Management LLC | 99,306 | $14,027,000 | 5.76% |
Casdin Capital, LLC | 312,000 | $44,070,000 | 5.36% |
Palo Alto Investors LP | 840,372 | $118,703,000 | 4.80% |
BB BIOTECH AG | 1,071,373 | $151,331,000 | 4.00% |
TRV GP II, LLC | 37,362 | $5,277,000 | 3.10% |
Eversept Partners, LP | 43,621 | $6,161,466 | 2.70% |
RA Capital Management | 350,933 | $49,569,000 | 2.65% |
Eventide Asset Management | 494,000 | $69,778,000 | 2.56% |
OAK RIDGE INVESTMENTS LLC | 241,099 | $34,055,000 | 1.88% |
SUFFOLK CAPITAL MANAGEMENT LLC | 93,000 | $13,136,000 | 1.87% |